Literature DB >> 2106131

Effect of amperozide on the synthesis and turnover of monoamines in rat brain.

G Pettersson1, K Johannessen, P Hulthe, J A Engel.   

Abstract

The effects of amperozide on the synthesis and the turnover of monoamines in different brain regions of the rat were determined using both ex vivo and in vivo biochemical techniques (i.e. post-mortem measurements of the tissue levels by HPLC-EC, and direct measurements with the in vivo voltammetry technique). It was found that amperozide slightly increased the DOPA accumulation and the DOPAC content in limbic brain areas but not in the striatum. The DOPA accumulation was also slightly increased in the noradrenaline rich cortical region indicating increased synthesis of noradrenaline. Furthermore, amperozide increased the utilization of noradrenaline after tyrosine hydroxylase inhibition by alpha-methyl-p-tyrosine. The synthesis of 5-HT was not significantly altered by amperozide. In conclusion, the biochemical data obtained in this study suggest that amperozide produces preferential effects on the mesolimbic dopaminergic system. In addition, amperozide also interacts with the noradrenergic system.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2106131     DOI: 10.1111/j.1600-0773.1990.tb01605.x

Source DB:  PubMed          Journal:  Pharmacol Toxicol        ISSN: 0901-9928


  3 in total

1.  The putatively antipsychotic agent amperozide produces behavioural stimulation in the rat. A behavioural and biochemical characterization.

Authors:  N Waters; G Pettersson; A Carlsson; K Svensson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-08       Impact factor: 3.000

2.  Effects of amperozide in schizophrenia. An open study of a potent 5-HT2 receptor antagonist.

Authors:  R Axelsson; A Nilsson; E Christensson; A Björk
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

3.  Systemic administration of amperozide, a new atypical antipsychotic drug, preferentially increases dopamine release in the rat medial prefrontal cortex.

Authors:  G G Nomikos; M Iurlo; J L Andersson; K Kimura; T H Svensson
Journal:  Psychopharmacology (Berl)       Date:  1994-06       Impact factor: 4.530

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.